Combined Effect of Smoking and Fatty Liver Disease on the Progression of Type 2 Diabetes: Insights from a Population-Based Cohort Study

<div>HRs and 95% CIs for incident type 2 diabetes. The numbers below each group indicate the number of participants who developed type 2 diabetes/participants classified in each group (percentage). The HRs and 95% CIs were calculated adjusting for sex, age, body mass index, waist circumference, exercise, fasting plasma glucose, hemoglobin A1c, SBP, DBP, total cholesterol, triglycerides, HDL cholesterol, and alanine transaminase at baseline. FL: fatty liver; non-: none.</div>

Computational and Mathematical Methods in Medicine

fig2

Figure 2

Figure 2: Combined Effect of Smoking and Fatty Liver Disease on the Progression of Type 2 Diabetes: Insights from a Population-Based Cohort Study 